Sign In
Buy LLY
$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
Rally Rockets: 3 Stocks Benefitting From the Market's Unstoppable Surge
02:44pm, Friday, 17'th May 2024
Major indices continue to climb Despite ongoing concerns over sticky inflation, high interest rates and geopolitical tensions. Many shares defy the traditional “sell in May and go away” adage.
Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control
01:01pm, Friday, 17'th May 2024
Eli Lilly's (LLY) two phase III studies on its once-weekly insulin, efsitora alfa, meet their primary endpoint of non-inferior reduction in blood sugar levels compared with daily basal insulins.
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
10:06am, Friday, 17'th May 2024
Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
3 Stocks to Buy Following Positive Earnings Results
05:11pm, Thursday, 16'th May 2024
All three of these companies saw buyers step up post-earnings, reflecting the positivity of their results.
3 Drug Stocks to Watch on Raised 2024 Earnings & Sales Guidance
11:15am, Thursday, 16'th May 2024
Here we discuss three drugmakers, Eli Lilly and Company (LLY), Novo Nordisk (NVO) and Merck (MRK), that have raised their earnings as well as sales guidance for 2024.
The Dividend Investor's Playbook: 3 Stocks for Consistent Cash Flow in 2024
08:13am, Thursday, 16'th May 2024
If you are looking for dividend stocks to buy, you're at the right place; research shows that companies regularly raising payouts, known as “dividend growers,” boast compound annual returns of abo
Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly
08:00am, Thursday, 16'th May 2024
Collaboration leverages Totus' covalent chemistry-based OmniDEL platform for the identification of small molecule drug candidates across multiple therapeutic areas Collaboration leverages Totus' coval
These 2 No-Brainer Growth Stocks Are Breaking New Ground
07:15am, Thursday, 16'th May 2024
Eli Lilly and Regeneron are developing competing hearing-loss gene therapies. These drugmakers have solid businesses thanks to their innovative qualities.
7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs
07:15am, Thursday, 16'th May 2024
It's no secret that artificial intelligence ( AI ) promises to transform every industry and sector, pharma included. But how do those companies plan to leverage AI, and what will it do for their stoc
Lilly's weekly insulin succeeds in late-stage studies
06:56am, Thursday, 16'th May 2024
Eli Lilly said on Thursday that its once-weekly insulin efsitora met the main goals in two late-stage trials evaluating it in people with type 2 diabetes.
With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin
06:45am, Thursday, 16'th May 2024
Efsitora met the primary endpoint in both QWINT-2 and QWINT-4 with once-a-week dosing regimen for people living with type 2 diabetes Efsitora was equally safe and effective among adults naïve to insu
Wall Street Favorites: 3 Growth Stocks With Strong Buy Ratings for May 2024
01:09pm, Wednesday, 15'th May 2024
If you think you've missed the rally in high-flying growth stocks, think again. Even though the market is close to all-time highs, many well-known growth stocks still have plenty of room to run.
Bullish On TOST & LLY
11:38am, Wednesday, 15'th May 2024
Should traders remain bullish with the current macro environment? Tom Plumb says that a good sustainable business plan, good people, disciplined allocation of capital, high return on capital, and prof
How Are Eli Lilly's Profit Margins Trending?
11:00am, Wednesday, 15'th May 2024
Eli Lilly (NYSE: LLY) saw its net income decline by $1 billion or 16% y-o-y to $5.2 billion in 2023. This can primarily be attributed to higher acquired in-process research and development expenses (I
Eli Lilly (LLY) Settles With Spa Selling Mounjaro, Zepbound Copies
10:56am, Wednesday, 15'th May 2024
Eli Lilly (LLY) reaches settlement with a medical spa selling copycat versions of Mounjaro and Zepbound. The spa will make a monetary payment to Lilly.
